Senate Hearing: Why U.S. Prescription Drug Prices Are the Highest in the World
January 1, 2022
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
The hearing explores the factors driving high drug costs for American consumers and the federal government, which directly impacts household healthcare affordability and federal spending on programs like Medicare.
Potentially affected actors named in the source documents. Mention is not a position.
American consumers
They pay the final retail prices for prescription drugs at pharmacies.
Pharmaceutical industry
They set the pricing structures and profit margins for prescription medications.
Medicare
The program is a major purchaser of prescription drugs and is subject to the pricing models discussed.
Last recorded activity January 1, 2022.
Next step not available in the current record.
Summary
Key Facts
- The hearing took place on March 23, 2021, in the Dirksen Senate Office Building.
- The U.S. pays the highest prices in the world for prescription drugs.
- U.S. healthcare spending is nearly double that of other countries.
- The pharmaceutical industry utilizes an opaque pricing system where different government branches may pay different prices for the same medication.
- The hearing included testimony from four primary witnesses: Aaron Kesselheim, Nav Persaud, Elia Spates, and Alex Brill.
- The National Council on Disability submitted a statement regarding Quality-Adjusted Life Years (QALYs).
Frequently Asked Questions
What was the purpose of this hearing?
Who participated in the hearing?
Why It Matters
The hearing explores the factors driving high drug costs for American consumers and the federal government, which directly impacts household healthcare affordability and federal spending on programs like Medicare.
News Coverage
Sponsors
Show 1 more sponsor
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Focus on Pricing Transparency
The hearing highlights a legislative focus on the lack of transparency in how pharmaceutical companies set drug prices.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance80How much this matters to a regular citizen
- Controversy60Intensity of disagreement among stakeholders
- Entertainment20Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools